Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells.

Liu ML, Zheng P, Liu Z, Xu Y, Mu J, Guo J, Huang T, Meng HQ, Xie P.

Mol Biosyst. 2014 Jul 29;10(9):2398-406. doi: 10.1039/c4mb00157e.

PMID:
24975926
2.

Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells.

Zheng P, Fang Z, Xu XJ, Liu ML, Du X, Zhang X, Wang H, Zhou J, Xie P.

J Affect Disord. 2016 May;195:75-81. doi: 10.1016/j.jad.2016.02.008. Epub 2016 Feb 5.

PMID:
26874244
3.

2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder.

Xu XJ, Zheng P, Ren GP, Liu ML, Mu J, Guo J, Cao D, Liu Z, Meng HQ, Xie P.

Mol Biosyst. 2014 Apr;10(4):813-9. doi: 10.1039/c3mb70614a. Epub 2014 Jan 24.

PMID:
24457555
4.

A novel urinary metabolite signature for diagnosing major depressive disorder.

Zheng P, Chen JJ, Huang T, Wang MJ, Wang Y, Dong MX, Huang YJ, Zhou LK, Xie P.

J Proteome Res. 2013 Dec 6;12(12):5904-11. doi: 10.1021/pr400939q. Epub 2013 Nov 26.

PMID:
24224655
5.

Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic study.

Liu ML, Zhang XT, Du XY, Fang Z, Liu Z, Xu Y, Zheng P, Xu XJ, Cheng PF, Huang T, Bai SJ, Zhao LB, Qi ZG, Shao WH, Xie P.

J Transl Med. 2015 Jul 14;13:226. doi: 10.1186/s12967-015-0540-y.

6.

Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.

Chen JJ, Zhou CJ, Liu Z, Fu YY, Zheng P, Yang DY, Li Q, Mu J, Wei YD, Zhou JJ, Huang H, Xie P.

J Proteome Res. 2015 Aug 7;14(8):3382-9. doi: 10.1021/acs.jproteome.5b00434. Epub 2015 Jul 20.

PMID:
26168936
7.

Peripheral blood mononuclear cell-based metabolomic profiling of a chronic unpredictable mild stress rat model of depression.

Li J, Tang G, Cheng K, Yang D, Chen G, Liu Z, Zhang R, Zhou J, Fang L, Fang Z, Du X, Xie P.

Mol Biosyst. 2014 Nov;10(11):2994-3001. doi: 10.1039/c4mb00388h.

PMID:
25182291
8.

Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action.

Xuan J, Pan G, Qiu Y, Yang L, Su M, Liu Y, Chen J, Feng G, Fang Y, Jia W, Xing Q, He L.

J Proteome Res. 2011 Dec 2;10(12):5433-43. doi: 10.1021/pr2006796. Epub 2011 Nov 8.

PMID:
22007635
9.

Potential metabolite markers of schizophrenia.

Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C.

Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.

10.

Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder.

Chen JJ, Liu Z, Fan SH, Yang DY, Zheng P, Shao WH, Qi ZG, Xu XJ, Li Q, Mu J, Yang YT, Xie P.

Sci Rep. 2014 Jul 28;4:5855. doi: 10.1038/srep05855.

11.

Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naïve schizophrenia patients after treatment with risperidone.

Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS.

J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.

PMID:
22800120
12.

Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.

Wu H, Xue R, Lu C, Deng C, Liu T, Zeng H, Wang Q, Shen X.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Oct 1;877(27):3111-7. doi: 10.1016/j.jchromb.2009.07.039. Epub 2009 Aug 7.

PMID:
19716777
13.

Metabolomic investigation into variation of endogenous metabolites in professional athletes subject to strength-endurance training.

Yan B, A J, Wang G, Lu H, Huang X, Liu Y, Zha W, Hao H, Zhang Y, Liu L, Gu S, Huang Q, Zheng Y, Sun J.

J Appl Physiol (1985). 2009 Feb;106(2):531-8. doi: 10.1152/japplphysiol.90816.2008. Epub 2008 Nov 26.

14.

Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.

Wu H, Xue R, Dong L, Liu T, Deng C, Zeng H, Shen X.

Anal Chim Acta. 2009 Aug 19;648(1):98-104. doi: 10.1016/j.aca.2009.06.033. Epub 2009 Jun 21.

PMID:
19616694
15.

Urinary metabolomic study of systemic lupus erythematosus based on gas chromatography/mass spectrometry.

Yan B, Huang J, Dong F, Yang L, Huang C, Gao M, Shi A, Zha W, Shi L, Hu X.

Biomed Chromatogr. 2016 Nov;30(11):1877-1881. doi: 10.1002/bmc.3734. Epub 2016 May 12.

PMID:
27061577
16.

Plasma metabolomic profiling of dairy cows affected with ketosis using gas chromatography/mass spectrometry.

Zhang H, Wu L, Xu C, Xia C, Sun L, Shu S.

BMC Vet Res. 2013 Sep 26;9:186. doi: 10.1186/1746-6148-9-186.

17.

[Metabolomics for Biomarker Discovery in Systemic Lupus Erythematosus].

Saegusa J, Kawano S, Morinobu A.

Rinsho Byori. 2015 Apr;63(4):498-505. Japanese.

PMID:
26536784
18.

Potential antidepressant and resilience mechanism revealed by metabolomic study on peripheral blood mononuclear cells of stress resilient rats.

Li J, Zhang SX, Wang W, Cheng K, Guo H, Rao CL, Yang DY, He Y, Zou DZ, Han Y, Zhao LB, Li PF, Xie P.

Behav Brain Res. 2017 Mar 1;320:12-20. doi: 10.1016/j.bbr.2016.11.035. Epub 2016 Nov 21.

PMID:
27880890
19.

Distinct urinary metabolic profile of human colorectal cancer.

Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W.

J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.

PMID:
22148915
20.

The metabolomic detection of lung cancer biomarkers in sputum.

Cameron SJ, Lewis KE, Beckmann M, Allison GG, Ghosal R, Lewis PD, Mur LA.

Lung Cancer. 2016 Apr;94:88-95. doi: 10.1016/j.lungcan.2016.02.006. Epub 2016 Feb 8.

Supplemental Content

Support Center